Cargando…
Hepatitis C Virus NS3 Inhibitors: Current and Future Perspectives
Currently, hepatitis C virus (HCV) infection is considered a serious health-care problem all over the world. A good number of direct-acting antivirals (DAAs) against HCV infection are in clinical progress including NS3-4A protease inhibitors, RNA-dependent RNA polymerase inhibitors, and NS5A inhibit...
Autores principales: | Salam, Kazi Abdus, Akimitsu, Nobuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825274/ https://www.ncbi.nlm.nih.gov/pubmed/24282816 http://dx.doi.org/10.1155/2013/467869 |
Ejemplares similares
-
Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase
por: Furuta, Atsushi, et al.
Publicado: (2015) -
PBDE: Structure-Activity Studies for the Inhibition of Hepatitis C Virus NS3 Helicase
por: Salam, Kazi Abdus, et al.
Publicado: (2014) -
Identification and Biochemical Characterization of Halisulfate 3 and Suvanine as Novel Inhibitors of Hepatitis C Virus NS3 Helicase from a Marine Sponge
por: Furuta, Atsushi, et al.
Publicado: (2014) -
Inhibition of Both Protease and Helicase Activities of Hepatitis C Virus NS3 by an Ethyl Acetate Extract of Marine Sponge Amphimedon sp
por: Fujimoto, Yuusuke, et al.
Publicado: (2012) -
A GC-rich sequence feature in the 3′ UTR directs UPF1-dependent mRNA decay in mammalian cells
por: Imamachi, Naoto, et al.
Publicado: (2017)